NasdaqGS:ASNDBiotechs
Assessing Ascendis Pharma (ASND) Valuation After Strong Multi Year Shareholder Returns
With no single headline event driving attention to Ascendis Pharma (NasdaqGS:ASND) today, the focus for investors leans toward how its recent share performance and financial profile might fit into a high-risk, high-reward biotech allocation.
See our latest analysis for Ascendis Pharma.
At a share price of $221.88, Ascendis Pharma has given investors a 10.95% 3 month share price return and a 33.67% 1 year total shareholder return. This reinforces a longer term total shareholder return of...